Neuberger Berman Group
DBTX

Neuberger Berman Group’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Neuberger Berman Group’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-58,800
Closed -$226K – 1896
2023
Q2 		$226K Buy
58,800
+43,139
+275% +$158K ﹤0.01% 1674
2023
Q1 		$47.3K Sell
15,661
-600
-4% -$2.07K ﹤0.01% 1769
2022
Q4 		$33.3K Sell
16,261
-52,339
-76% -$159K ﹤0.01% 1752
2022
Q3 		$237K Sell
68,600
-400
-0.6% -$1.82K ﹤0.01% 1684
2022
Q2 		$290K Buy
69,000
+6,175
+10% +$14.6K ﹤0.01% 1654
2022
Q1 		$191K Buy
62,825
+3,255
+5% +$12.5K ﹤0.01% 1815
2021
Q4 		$277K Buy
59,570
+16,035
+37% +$110K ﹤0.01% 1752
2021
Q3 		$336K Buy
43,535
+185
+0.4% +$1.41K ﹤0.01% 1565
2021
Q2 		$373K Buy
43,350
+15,350
+55% +$135K ﹤0.01% 1542
2021
Q1 		$318K Buy
+28,000
New +$439K ﹤0.01% 1594

Other funds holding DBTX

ACA
Atlas Capital Advisors Jackson, Wyoming $914M AUM

Neuberger Berman Group's DBTX Position: Q3 2023 in Review

Neuberger Berman Group sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 58,800 shares — an estimated $226K sold.

Neuberger Berman Group first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $373K in Q2 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

  • Neuberger Berman Group reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Neuberger Berman Group sold 58,800 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $226K.
  • Neuberger Berman Group first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Neuberger Berman Group's Decibel Therapeutics, Inc. Common Stock position peaked at $373K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Neuberger Berman Group's 13F filing for Q3 2023, filed 14 Nov 2023.